Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
PRRUF
Stock Latest News
Company Announcements
Immutep Ltd Highlights Immune System Innovations at Healthcare Conference
6d ago
Premium
The Fly
Immutep announces EFTISARC-NEO Phase II trial met primary endpoint
11d ago
IMMP
Premium
Company Announcements
Immutep’s Efti Combination Therapy Achieves Success in Phase II Soft Tissue Sarcoma Trial
13d ago
Premium
Ratings
Immutep’s Promising Phase 1 INSIGHT-003 Results Drive Buy Rating
19d ago
IMMP
Premium
The Fly
Immutep announces response rates from INSIGHT-003 trial
23d ago
IMMP
Premium
Company Announcements
Immutep’s Efti Combination Shows Promising Results in Lung Cancer Trial
24d ago
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
MRK
ATHE
Premium
Ratings
Immutep’s Promising Phase 2b Results and Strong Financial Position Justify Buy Rating
1M ago
IMMP
Premium
The Fly
Immutep announces results from Phase IIb trial of TACTI-003
1M ago
MRK
IMMP
Premium
Company Announcements
Immutep’s Efti Shows Promising Results in Head and Neck Cancer Trial
1M ago
Premium
The Fly
Immutep reports Q3 cash receipts from customers A$12,000
1M ago
IMMP
Premium
Company Announcements
Immutep Advances Cancer Trials with Promising Developments
1M ago
Premium
Company Announcements
Immutep Advances in NSCLC Treatment with TACTI-004 Trial
2M ago
Premium
Company Announcements
Immutep Director Increases Stake Through Performance Rights Exercise
2M ago
Premium
Company Announcements
Immutep Ltd Director Increases Shareholding Through Performance Rights Conversion
2M ago
Premium
Company Announcements
Immutep Ltd Issues 4.8 Million New Securities on ASX
2M ago
Premium
Company Announcements
Immutep to Engage in Key Investor Conferences
2M ago
Premium
Ratings
Immutep’s Promising Clinical Developments and Strategic Collaborations Earn a Buy Rating
2M ago
IMMP
Premium
The Fly
Immutep announces first patient dosed in TACTI-004 Phase III trial
2M ago
IMMP
Premium
Company Announcements
Immutep Doses First Patient in Pivotal Phase III Lung Cancer Trial
2M ago
Premium
The Fly
Immutep announces poster presentation for the TACTI-004 Phase III trial
3M ago
MRK
IMMP
Premium
Company Announcements
Immutep to Present Pivotal Lung Cancer Trial at ELCC 2025
3M ago
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.